- SEQoL, one year on One year ago, Anthony Nolan launched its landmark study aiming to understand the impact of a stem cell transplant on quality of life. Now, we reflect…
- The lifesaving potential of cordblood Around 1,400 people in the UK receive a potentially lifesaving stem cell transplant from an unrelated donor each year. But there…
- Last week, new UK-wide regulations aiming to get personalised treatments like CAR-T to patients faster became active. The Human Medicines (Amendment) (Modular Manufacture…
- The hope of PTCy Stem cell transplants can be a lifesaving treatment for someone with a blood cancer or blood disorder. But they often require a close genetic match to…
- Cord blood provides an important graft source, especially for patients with limited adult donor options and those with particularly resistant leukaemia. Complexity of the clinical…
- Anthony Nolan has changed the landscape of blood cancer treatments in many ways over the years. Breakthrough after breakthrough has been produced in our laboratories thanks to the…
- It’s World Cancer Research Day – but at Anthony Nolan, our researchers pour their passion into discovering treatments and cures for blood cancers every day. Hundreds of clinical…
- Image courtesy of Dr Kevin Rouault-Pierre's lab Anthony Nolan’s Cell & Gene Therapy (CGT) team are proud to announce the release of new research from Queen Mary…
- Foot ulcers can be debilitating for people with diabetes, and cost the NHS more than £1 billion each year. Belfast biotech company VascVersa aims to develop a cell therapy to…
- We caught up with Sandra Frater, head of clinical support in our laboratories team, on the changes she’s seen in her 25-year career with Anthony Nolan, and what the future holds…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.